ECDC

World Hepatitis Summit 2024 Convenes in Lisbon

Retrieved on: 
목요일, 4월 4, 2024
Vaccination, Summit, WHO, Diagnosis, WHA, Viral hepatitis, ECDC, Friends, Policy, WHS, Family, Treatment, Private sector, Hepatitis B, COVID-19, Hepatitis, Vaccine

The World Hepatitis Summit (WHS) 2024 Will Bring Together Global Experts to Discuss the Latest Advances in Hepatitis Prevention, Diagnosis and Treatment

Key Points: 
  • The World Hepatitis Summit (WHS) 2024 Will Bring Together Global Experts to Discuss the Latest Advances in Hepatitis Prevention, Diagnosis and Treatment
    LONDON, Apr 4, 2024 - (ACN Newswire) - The World Hepatitis Summit (WHS) 2024 convenes in Lisbon from 9 - 11 April and will bring together global experts to discuss the latest advances in hepatitis prevention, diagnosis and treatment.
  • At the Summit, the World Hepatitis Alliance (WHA) and The European Centre for Disease Prevention and Control (ECDC) will present findings from a first-of-its-kind report examining levels of stigma and discrimination surrounding people living with hepatitis in Europe.
  • The report finds that half (50%) of those living with hepatitis B and C struggle to tell people about their hepatitis.
  • On the opening day of the Summit, WHO will release its 2024 Global Hepatitis Report.

Press release - EU pharmaceutical policy: MEPs support comprehensive reform

Retrieved on: 
수요일, 4월 3, 2024
Health, ERA, Environment, Public health, EPP, Patient, Eras, Research, Food safety, S&D, Prescription, AMR, Commission, Parliament, European Medicines Agency, Council, HERA, Atmosphere, Water, Soil, Marketing, ECDC, Rapporteur, Medication, Pharmaceutical industry

MEPs adopted their proposals to revamp EU pharmaceutical legislation, to foster innovation and enhance the security of supply, accessibility and affordability of medicines.Committee on the Environment, Public Health and Food Safety Source : © European Union, 2024 - EP

Key Points: 


MEPs adopted their proposals to revamp EU pharmaceutical legislation, to foster innovation and enhance the security of supply, accessibility and affordability of medicines.Committee on the Environment, Public Health and Food Safety Source : © European Union, 2024 - EP

Er-Kim Pharmaceuticals Supports Worldwide Prevention of Antimicrobial Resistance (AMR)

Retrieved on: 
금요일, 11월 24, 2023
Western world, ECDC, CFO, AMR, WAAW, Infection, Public, European, Patient, Bacteria, Pharmaceutical industry

BUCHAREST, Romania, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Er-Kim Pharmaceuticals , an international pharmaceutical company specializing in the commercialization of novel therapies, joins the industry to collaborate on the prevention of antimicrobial resistance (AMR) in support of World AMR Awareness Week , a global campaign to promote understanding of antimicrobial resistance (AMR).

Key Points: 
  • BUCHAREST, Romania, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Er-Kim Pharmaceuticals , an international pharmaceutical company specializing in the commercialization of novel therapies, joins the industry to collaborate on the prevention of antimicrobial resistance (AMR) in support of World AMR Awareness Week , a global campaign to promote understanding of antimicrobial resistance (AMR).
  • Previously named World Antimicrobial Awareness Week or WAAW, World AMR Awareness Week is recognized every year from 18 to 24 November.
  • The rapid emergence of resistant bacteria is occurring worldwide and threatening the efficacy of existing antibiotics.
  • Together, we can effectively address the global challenge of antimicrobial resistance.

Empowering Colombia's Future Through Education; ADFD's Commitment to Colombia's Early Childhood Development

Retrieved on: 
수요일, 10월 11, 2023
Preschool, Other Philanthropy, General Health, Health, Other Education, Continuing, Philanthropy, Education, Abu Dhabi Fund for Development, Partnership, Multimedia, Sustainable Development Goals, SDG, Pregnancy, United States Secretary of Labor, Growth, Early childhood, ECDC, Sustainable Development Goal 4, Child, Quality of life, Tourism, Toy

The Early Childhood Development Centers (ECDC) project in Colombia, supported by an allocation of US$10.5 million from the Abu Dhabi Fund for Development (ADFD), stands as a testament to the UAE's commitment to the Sustainable Development Goals (SDGs).

Key Points: 
  • The Early Childhood Development Centers (ECDC) project in Colombia, supported by an allocation of US$10.5 million from the Abu Dhabi Fund for Development (ADFD), stands as a testament to the UAE's commitment to the Sustainable Development Goals (SDGs).
  • The project in partnership with international organizations, has facilitated the establishment of 37 Early Childhood Development Centers, guaranteeing education for hundreds of children below the age of six.
  • As trained professionals offer expert care, from pregnancy to early childhood, ensuring optimal growth and well-being.
  • By investing in early childhood education in Colombia, the UAE is contributing to the larger global mission of ensuring inclusive and equitable education for all.

Findings Spotlight Urgent Need for Europe to Step-up on AIDS, says AHF

Retrieved on: 
수요일, 9월 20, 2023
AIDS, Philanthropy, Public Policy, Government, Health, Healthcare Reform, Advocacy Group Opinion, Foundation, AHF, HIV/AIDS, Diagnosis, Policy, Investment, HIV, AIDS Healthcare Foundation, European Centre for Disease Prevention and Control, ECDC, Medical device

“Progress in curbing new HIV transmissions in Europe and globally is far too slow to meet the global target of ending AIDS by 2030.

Key Points: 
  • “Progress in curbing new HIV transmissions in Europe and globally is far too slow to meet the global target of ending AIDS by 2030.
  • To win the battle against AIDS, all people living with HIV must know their status, stay on treatment, and remain virally suppressed,” said AHF Chief of Global Advocacy and Policy Terri Ford.
  • “But those critical aspects of the AIDS response aren’t possible without increased investments by countries to find people who don’t know they’re HIV positive and get and retain them in care.
  • From January to August 2023, AHF teams in Europe tested over 125,000 people for HIV.

Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances

Retrieved on: 
토요일, 6월 10, 2023
Enterobacteriaceae, University of Zurich, XDR, Probability, The BMJ, University, Medical journal, Prevalence, Science Advances, Infection, Colistin, AMR, European Centre for Disease Prevention and Control, USD, Klebsiella pneumoniae, CDC, Death, MDR, MICS, Patient, Manuscript, ECDC, Korea Disease Control and Prevention Agency, Klebsiella, Mortality, WHO, Lancet, Gene, Escherichia coli, World Health Organization, Pharmaceutical industry, Antibiotics, Vaccine, Science, Spexy Beast, Tata LPTA

The manuscript, titled “Peptidomimetic Antibiotics Disrupt the Lipopolysaccharide Transport Bridge of Drug-Resistant Enterobacteriaceae,” is available online in the international peer-reviewed journal Science Advances at: https://www.science.org/doi/10.1126/sciadv.adg3683 .

Key Points: 
  • The manuscript, titled “Peptidomimetic Antibiotics Disrupt the Lipopolysaccharide Transport Bridge of Drug-Resistant Enterobacteriaceae,” is available online in the international peer-reviewed journal Science Advances at: https://www.science.org/doi/10.1126/sciadv.adg3683 .
  • In the United States, more than 2.8 million antimicrobial-resistant infections occur each year, leading to over 35,000 deaths and an estimated USD 4.6 billion in healthcare costs.
  • Recent discovery of plasmid-mediated transferable colistin resistance genes have shown the ease with which resistance can spread in bacterial populations.
  • No cross-resistance with standard of care antibiotics was observed and the demonstrated Enterobacteriaceae-specificity versus broad-spectrum activity supports continued development for this class of antibiotics for the potential management and treatment of antimicrobial resistant pathogens.

Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances demonstrating potent in vitro and in vivo antimicrobial activity against MDR and XDR Enterobacteriaceae, including carba

Retrieved on: 
수요일, 6월 7, 2023
Enterobacteriaceae, University of Zurich, XDR, Probability, The BMJ, University, Medical journal, Prevalence, Science Advances, Infection, Colistin, AMR, European Centre for Disease Prevention and Control, USD, Klebsiella pneumoniae, CDC, Death, MDR, MICS, Patient, Manuscript, ECDC, Korea Disease Control and Prevention Agency, Klebsiella, Mortality, WHO, Lancet, Gene, Escherichia coli, World Health Organization, Pharmaceutical industry, Vaccine, Antibiotics, Science, Spexy Beast, Tata LPTA

The manuscript, titled “Peptidomimetic Antibiotics Disrupt the Lipopolysaccharide Transport Bridge of Drug-Resistant Enterobacteriaceae,” is available online in the international peer-reviewed journal Science Advances at: https://www.science.org/doi/10.1126/sciadv.adg3683 .

Key Points: 
  • The manuscript, titled “Peptidomimetic Antibiotics Disrupt the Lipopolysaccharide Transport Bridge of Drug-Resistant Enterobacteriaceae,” is available online in the international peer-reviewed journal Science Advances at: https://www.science.org/doi/10.1126/sciadv.adg3683 .
  • Antimicrobial resistance (AMR) has emerged as a significant threat for both patients and healthcare systems.
  • In the United States, more than 2.8 million antimicrobial-resistant infections occur each year, leading to over 35,000 deaths and an estimated USD 4.6 billion in healthcare costs.
  • The compounds showed potent in vivo efficacy, especially in lung infection models as well as a promising in vitro and in vivo safety profile.

Highlights - Vote on 2021 Discharge: European Commission, EDF, Agencies - Committee on Budgetary Control

Retrieved on: 
토요일, 3월 18, 2023
ENISA, EEA, EDF, Agency, EUROJUST, European Labour Authority, Civil service commission, European Public Prosecutor's Office, EIOPA, Commission, EPP, EUROPOL, EMCDDA, ECHA, EBA, CEPOL, Global Europe, Rapporteur, CDT, FRA, European Parliament Committee on Budgetary Control, Parliament, ERA, Committee, EMA, EUSPA, EIT, EMSA, ETF, ECDC, EFSA, ELA, Recovery, EFCA, BEREC, ACER, European High-Performance Computing Joint Undertaking, ESMA, EASA, Eu-LISA, European Commission, Language industry, Renewable energy, EU, EASO

Vote on 2021 Discharge: European Commission, EDF, Agencies

Key Points: 
  • Vote on 2021 Discharge: European Commission, EDF, Agencies
    17-03-2023 - 12:32
    On 22 March 2023, the Members of the Committee for Budgetary Control will vote on the draft reports and amendments concerning the 2021 Discharge to the European Commission, European Development Fund (EDF), and Agencies.
  • The vote is the second batch for the 2021 discharge, after votes on the discharge for the Parliament, other Institutions and the Joint Undertakings on 28 February 2023.
  • The discharge procedure has proven to be a powerful tool to oversee the spending of EU money.
  • Novelties this year are the first discharge for the European Public Prosecutors Office and the European Labour Authority and the inclusion of the Recovery and Resilience Facility in the Commission discharge.

Highlights - Discharge 2021 - Consideration of Draft Reports - Committee on Budgetary Control

Retrieved on: 
목요일, 2월 2, 2023
CDT, ELA, European Parliament Committee on Budgetary Control, EPP, EBA, EUSPA, EMCDDA, EMA, EIOPA, EEA, Commission, ESMA, EFSA, Council, Royal commission, EFCA, CEPOL, EUROPOL, Committee, Parliament, BEREC, ENISA, FRA, European Development Fund, ECHA, EIT, EMSA, ERA, EDF, Rapporteur, EASA, ECDC, ETF, Eu-LISA, Strategic autonomy, ACER, EUROJUST, European Commission, Animal, Language industry, Renewable energy, EASO, EU

Discharge 2021: Consideration of Draft Reports

Key Points: 
  • Discharge 2021: Consideration of Draft Reports
    02-02-2023 - 11:48
    On 9 February 2023, the Committee on Budgetary Control will consider the draft discharge reports for the European Commission, the European Development Fund, and EU Agencies.
  • The draft reports will be presented by their respective Rapporteurs, presenting what they consider to be the main points for the 2021 discharge cycle.
  • In the draft reports presented in this meeting, the CONT Committee scrutinises how the Commission and EU Agencies are implementing the EU budget and prepares the Parliament's discharge decisions.
  • Parliament considers the reports prepared by the Budgetary Control Committee, taking into account the Council's recommendations, and decides to grant, postpone or refuse a discharge.

Highlights - 2021 Discharge: Hearing with Agencies - Committee on Budgetary Control

Retrieved on: 
화요일, 11월 29, 2022
EUROJUST, European Medicines Agency, ECHA, ENISA, ESMA, ECDC, European Agency for Special Needs and Inclusive Education, EEA, Hearing, EASA, EMA, Director, CDT, ETF, EMSA, ACER, EIOPA, ERA, Area of freedom, security and justice, Strategic autonomy, European Operations Management Association, ELA, European Parliament Committee on Budgetary Control, Security, EFCA, EUROPOL, Committee, European Union Agency for the Space Programme, Eu-LISA, EMCDDA, ECA, CEPOL, Justice, EBA, EUSPA, Area, ESA, EIT, BEREC, FRA, EFSA, EU, Renewable energy

2021 Discharge: Hearing with Agencies

Key Points: 
  • 2021 Discharge: Hearing with Agencies
    29-11-2022 - 12:18
    On 30 November 2022, in the framework of the 2021 discharge cycle, the Committee on Budgetary Control will hold a hearing with the Chair of the EU Agencies Network and three decentralised European Agencies (eu-LISA, EUAA, and EMA).
  • The CONT Committee will hold a hearing with Hans Bruyninckx, outgoing Chair of the EU Agencies Network, as well as with the Executive Directors of the European Union Agency for the Operational Management of Large-Scale IT Systems in the Area of Freedom, Security and Justice (eu-LISA), the European Union Agency for Asylum (EUAA), and the European Medicines Agency (EMA).
  • The hearing will be held in the presence of the ECA reporting member Mihails Kozlovs.
  • - Rapporteur Agencies: Gilles Boyer (Renew) for EIOPA, ESMA
    - Rapporteur: Olivier Chastel (Renew) for CdT, Cedefop, EASA, EIGE, ERA, Eurofound, Horizontal Report
    - Rapporteur Agencies: Katalin Cseh (Renew) for ACER, BEREC, ECDC, ECHA, EEA, EFSA, EIT, EMA, ENISA, ESA, EUSPA
    - Rapporteur Agencies: Pierre Karleskind (Renew) for EFCA, EMSA
    - Rapporteur Agencies: Alin Mitua (Renew) for EBA, ELA, ETF, EU-OSHA
    - Rapporteur Agencies: Ramona Strugariu (Renew) for CEPOL, EMCDDA, EUAA, eu-LISA, EUROJUST, EUROPOL, FRA, Frontex
    - 2021 Agencies Discharge